Recent progress of supramolecular chemotherapy based on host–guest interactions

M Yan, S Wu, Y Wang, M Liang, M Wang… - Advanced …, 2024 - Wiley Online Library
Chemotherapy is widely recognized as an effective approach for treating cancer due to its
ability to eliminate cancer cells using chemotherapeutic drugs. However, traditional …

Recent advances in host–guest self‐assembled cyclodextrin carriers: Implications for responsive drug delivery and biomedical engineering

J Wankar, NG Kotla, S Gera, S Rasala… - Advanced Functional …, 2020 - Wiley Online Library
This Review is an overview of the unique characteristics of cyclodextrin in forming an
inclusion complex via host–guest noncovalent interactions. The modification of cyclodextrin …

Recent advances in folic acid engineered nanocarriers for treatment of breast cancer

P Tagde, GT Kulkarni, DK Mishra… - Journal of Drug Delivery …, 2020 - Elsevier
Breast cancer is one of the most prevalent types of cancer among female patients, which is
caused by mutations in the oestrogen/progesterone receptors. Conventional treatment …

Amphiphilic cyclodextrin nanoparticles

G Varan, C Varan, N Erdoğar, AA Hıncal… - International journal of …, 2017 - Elsevier
Cyclodextrins are cyclic oligosaccharides obtained by enzymatic digestion of starch. The α-,
β-and γ-cyclodextrins contain respectively 6, 7 and 8 glucopyranose units, with primary and …

Alkali/alkaline earth-based metal–organic frameworks for biomedical applications

G Ye, C Chen, J Lin, X Peng, A Kumar, D Liu… - Dalton Transactions, 2021 - pubs.rsc.org
With the steady development of metal–organic framework (MOF) materials, this peculiar
class of three-dimensional materials has found application prospects in a myriad of areas …

Investigation of effective parameters on size of paclitaxel loaded PLGA nanoparticles

F Madani, SS Esnaashari, B Mujokoro… - Advanced …, 2018 - pmc.ncbi.nlm.nih.gov
Purpose: The size of polymeric nanoparticles is considered as an effective factor in cancer
therapy due to enterance into tumor tissue via the EPR effect. The purpose of this work was …

Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy

F Raza, H Zafar, MW Khan, A Ullah, AU Khan… - Materials …, 2022 - pubs.rsc.org
Cancer cases have reached an all-time high in the current era. Thus, there is a need to
develop advanced therapeutic methods that can effectively inhibit the proliferation of …

Progress and prospects of modified starch-based carriers in anticancer drug delivery

B Zhao, L Li, X Lv, J Du, Z Gu, Z Li, L Cheng… - Journal of Controlled …, 2022 - Elsevier
Recently, the role of starch-based carrier systems in anticancer drug delivery has gained
considerable attention. Although there are same anticancer drugs, difference in their …

Starch-based carriers of paclitaxel: A systematic review of carriers, interactions, and mechanisms

B Zhao, Z Gu, Y Zhang, Z Li, L Cheng, C Li… - Carbohydrate Polymers, 2022 - Elsevier
Paclitaxel, a clinical chemotherapy drug commonly used in the past few years, is greatly
limited by its low therapeutic index. Starch and its derivatives have gained wide interest from …

[PDF][PDF] Application of the CRISPR/Cas9 system to drug resistance in breast cancer

Y Chen, Y Zhang - Advanced Science, 2018 - Wiley Online Library
Clinical evidence indicates that drug resistance is a great obstacle in breast cancer therapy.
It renders the disease uncontrollable and causes high mortality. Multiple mechanisms …